Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

3,4-dihydroxyethylamphetamine

Known as: (OH)2-Et-amphetamine 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Amphetamines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Investigations on the stereoselectivity of the phase II metabolism of the 3,4-methylenedioxyethylamphetamine (MDEA) metabolites 3,4-dihydroxyethylamphetamine (DHEA) and 4-hydroxy-3…
Different elimination was reported for the two enantiomers of the designer drug 3,4-methylenedioxyethylamphetamine (MDEA) in vivo… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Metabolism of racemic 3,4-methylenedioxyethylamphetamine in humans. Isolation, identification, quantification, and synthesis of urinary metabolites.
Studies on the isolation, identification, quantification, and synthesis of the urinary metabolites of racemic 3,4… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Toxicological detection of the designer drug 3,4-methylenedioxyethylamphetamine (MDE, "Eve") and its metabolites in urine by gas chromatography-mass spectrometry and fluorescence polarization…
Studies are presented on the toxicological detection of the designer drug methylenedioxyethylamphetamine [MDE, rac-N-ethyl-(3,4… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE